All Pharma News
NRx Pharma Announces Advance of $5 Million Milestone Payment from Alvogen

NRx Pharma Announces Advance of $5 Million Milestone Payment from Alvogen
PR NEWSWIRE
11 Feb 2024
Share Share
Alvogen snags NRx`s bipolar depression drug in $330M deal

Alvogen snags NRx`s bipolar depression drug in $330M deal
Nick Paul Taylor FIERCE BIOTECH
07 Jun 2023
Share Share
Enforcement Report - Week of March 8, 2023

Enforcement Report - Week of March 8, 2023
FDA
08 Mar 2023
Share Share
AZ hit with fine in Korea over plot to stall generic of lucrative cancer med

AZ hit with fine in Korea over plot to stall generic of lucrative cancer med
Fraiser Kansteiner FIERCEPHARMA
14 Oct 2022
Share Share
Bausch Health Responds to Norwich Tentative FDA Approval for a 200 mg Rifaximin

Bausch Health Responds to Norwich Tentative FDA Approval for a 200 mg Rifaximin
PRNEWSWIRE
09 Sep 2022
Share Share
Norwich`s Generic Rifaximin Receives Approval in the U.S.

Norwich`s Generic Rifaximin Receives Approval in the U.S.
FDA
02 Sep 2022
Share Share
Alvogen Announces Ruling on Patents Related to the Company’s Proposed Generic

Alvogen Announces Ruling on Patents Related to the Company’s Proposed Generic
BUSINESSWIRE
11 Aug 2022
Share Share
Alvogen Generic Nitrofurantoin Receives Approval in the U.S.

Alvogen Generic Nitrofurantoin Receives Approval in the U.S.
FDA
20 Jul 2022
Share Share
Norwich Pharma`s Generics Lisdexamfetamine Dimesylate Receives Approval in US

Norwich Pharma`s Generics Lisdexamfetamine Dimesylate Receives Approval in US
FDA
21 Jun 2022
Share Share
Aztiq and Innobic conclude acquisition of AEMH for $500m

Aztiq and Innobic conclude acquisition of AEMH for $500m
PHARMACEUTICAL-TECHNOLOGY
10 May 2022
Share Share